These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
294 related articles for article (PubMed ID: 22797736)
21. District Health Officer Perceptions of PEPFAR's Influence on the Health System in Uganda, 2005-2011. Lohman N; Hagopian A; Luboga SA; Stover B; Lim T; Makumbi F; Kiwanuka N; Lubega F; Ndizihiwe A; Mukooyo E; Barnhart S; Pfeiffer J Int J Health Policy Manag; 2017 Feb; 6(2):83-95. PubMed ID: 28812783 [TBL] [Abstract][Full Text] [Related]
22. "What took you so long?" The impact of PEPFAR on the expansion of HIV testing and counseling services in Africa. Marum E; Taegtmeyer M; Parekh B; Mugo N; Lembariti S; Phiri M; Moore J; Cheng AS J Acquir Immune Defic Syndr; 2012 Aug; 60 Suppl 3():S63-9. PubMed ID: 22797742 [TBL] [Abstract][Full Text] [Related]
23. Programmatic mapping and estimating the population size of female sex workers, men who have sex with men, people who inject drugs and transgender populations in Kenya. Musimbi J; Musyoki H; Mugambi M; Kaosa S; Kioko J; Aluko D; Wanjiru W; Wambua S; Prakash R; Isac S; Bhattacharjee P; Emmanuel F Gates Open Res; 2022; 6():112. PubMed ID: 39035422 [TBL] [Abstract][Full Text] [Related]
24. The use of epidemiological data to inform the PEPFAR response. Lyerla R; Murrill CS; Ghys PD; Calleja-Garcia JM; DeCock KM J Acquir Immune Defic Syndr; 2012 Aug; 60 Suppl 3():S57-62. PubMed ID: 22797741 [TBL] [Abstract][Full Text] [Related]
25. Trends in HIV prevalence among people injecting drugs, men having sex with men, and female sex workers in Ukraine. Dumchev K; Sazonova Y; Salyuk T; Varetska O Int J STD AIDS; 2018 Nov; 29(13):1337-1344. PubMed ID: 30049259 [TBL] [Abstract][Full Text] [Related]
26. Replicating PEPFAR's success: how interventions shown to be effective abroad can be applied to the AIDS epidemic in the US. Fu J; Gavaghan A; Millett G; Walsh T Health Aff (Millwood); 2012 Jul; 31(7):1585-92. PubMed ID: 22778349 [TBL] [Abstract][Full Text] [Related]
27. Key harm reduction interventions and their impact on the reduction of risky behavior and HIV incidence among people who inject drugs in low-income and middle-income countries. Dutta A; Wirtz AL; Baral S; Beyrer C; Cleghorn FR Curr Opin HIV AIDS; 2012 Jul; 7(4):362-8. PubMed ID: 22647588 [TBL] [Abstract][Full Text] [Related]
28. Peer community health workers improve HIV testing and ART linkage among key populations in Zambia: retrospective observational results from the Z-CHECK project, 2019-2020. Lindsay BR; Mwango L; Toeque MG; Malupande SL; Nkhuwa E; Moonga CN; Chilambe A; Sakala H; Kafunda I; Olowski P; Olufunso A; Okuku J; Kancheya N; Mumba D; Hachaambwa L; Sheneberger R; Blanco N; Lavoie MC; Claassen CW J Int AIDS Soc; 2022 Nov; 25(11):e26030. PubMed ID: 36317821 [TBL] [Abstract][Full Text] [Related]
29. Building sustainable organizational capacity to deliver HIV programs in resource-constrained settings: stakeholder perspectives. Sharma A; Chiliade P; Michael Reyes E; Thomas KK; Collens SR; Rafael Morales J Glob Health Action; 2013 Dec; 6():22571. PubMed ID: 24331715 [TBL] [Abstract][Full Text] [Related]
30. Monitoring HIV and AIDS Related Policy Reforms: A Road Map to Strengthen Policy Monitoring and Implementation in PEPFAR Partner Countries. Lane J; Verani A; Hijazi M; Hurley E; Hagopian A; Judice N; MacInnis R; Sanford S; Zelek S; Katz A PLoS One; 2016; 11(2):e0146720. PubMed ID: 26914708 [TBL] [Abstract][Full Text] [Related]
31. The United States President's Emergency Plan for AIDS Relief: a story of partnerships and smart investments to turn the tide of the global AIDS pandemic. Goosby E; Dybul M; Fauci AS; Fu J; Walsh T; Needle R; Bouey P J Acquir Immune Defic Syndr; 2012 Aug; 60 Suppl 3():S51-6. PubMed ID: 22797740 [TBL] [Abstract][Full Text] [Related]
32. Advancing Programme Science approaches to understand gaps in HIV prevention programme coverage for key populations in 12 Nigerian states: findings from the 2020 Integrated Biological and Behavioural Surveillance Survey. McClarty LM; Green K; Leung S; Ejeckam C; Adesina A; Shaw SY; Neufeld B; Isac S; Emmanuel F; Blanchard JF; Aliyu G J Int AIDS Soc; 2024 Jul; 27 Suppl 2(Suppl 2):e26269. PubMed ID: 38988042 [TBL] [Abstract][Full Text] [Related]
33. Current allocations and target apportionment for HIV testing and treatment services for marginalized populations: characterizing PEPFAR investment and strategy. Jones A; Honermann B; Lankiewicz E; Sherwood J; Millett G J Int AIDS Soc; 2021 Jul; 24 Suppl 3(Suppl 3):e25753. PubMed ID: 34189858 [TBL] [Abstract][Full Text] [Related]
34. Global Trends of Monitoring and Data Collection on the HIV Response among Key Populations Since the 2001 UN Declaration of Commitment on HIV/AIDS. Gall J; Sabin K; Frescura L; Sabin ML; Erkkola T; Toskin I AIDS Behav; 2017 Jul; 21(Suppl 1):34-43. PubMed ID: 27896550 [TBL] [Abstract][Full Text] [Related]
35. A Systematic Review of Gender-Based Violence Prevention and Response Interventions for HIV Key Populations: Female Sex Workers, Men Who Have Sex With Men, and People Who Inject Drugs. Decker MR; Lyons C; Guan K; Mosenge V; Fouda G; Levitt D; Abelson A; Nunez GT; Njindam IM; Kurani S; Baral S Trauma Violence Abuse; 2022 Apr; 23(2):676-694. PubMed ID: 35144502 [TBL] [Abstract][Full Text] [Related]
36. Creating a national culture of quality: the Tanzania experience. Mwidunda PE; Eliakimu E AIDS; 2015 Jul; 29 Suppl 2():S175-7. PubMed ID: 26102628 [TBL] [Abstract][Full Text] [Related]
37. HIV decline associated with changes in risk behaviours among young key populations in Nepal: analysis of population-based HIV prevalence surveys between 2001 and 2012. Deuba K; Ekström AM; Tomson G; Shrestha R; Marrone G Int J STD AIDS; 2017 Aug; 28(9):864-875. PubMed ID: 27799419 [TBL] [Abstract][Full Text] [Related]
38. National HIV Care Continua for Key Populations. Gupta S; Granich R J Int Assoc Provid AIDS Care; 2017; 16(2):125-132. PubMed ID: 28090799 [TBL] [Abstract][Full Text] [Related]
39. Revitalizing the HIV response in Pakistan: a systematic review and policy implications. Singh S; Ambrosio M; Semini I; Tawil O; Saleem M; Imran M; Beyrer C Int J Drug Policy; 2014 Jan; 25(1):26-33. PubMed ID: 23810289 [TBL] [Abstract][Full Text] [Related]